Your browser doesn't support javascript.
loading
Evidence in primates supporting the use of chemogenetics for the treatment of human refractory neuropsychiatric disorders.
Roseboom, Patrick H; Mueller, Sascha A L; Oler, Jonathan A; Fox, Andrew S; Riedel, Marissa K; Elam, Victoria R; Olsen, Miles E; Gomez, Juan L; Boehm, Matthew A; DiFilippo, Alexandra H; Christian, Bradley T; Michaelides, Michael; Kalin, Ned H.
Affiliation
  • Roseboom PH; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA. Electronic address: roseboom@wisc.edu.
  • Mueller SAL; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
  • Oler JA; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
  • Fox AS; Department of Psychology and the California National Primate Research Center, University of California-Davis, Davis, CA 95616, USA.
  • Riedel MK; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
  • Elam VR; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
  • Olsen ME; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
  • Gomez JL; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA.
  • Boehm MA; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA.
  • DiFilippo AH; Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
  • Christian BT; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA; Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
  • Michaelides M; Biobehavioral Imaging and Molecular Neuropsychopharmacology Unit, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA.
  • Kalin NH; Department of Psychiatry and the HealthEmotions Research Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI 53719, USA.
Mol Ther ; 29(12): 3484-3497, 2021 12 01.
Article in En | MEDLINE | ID: mdl-33895327
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clozapine / Neurons Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clozapine / Neurons Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2021 Type: Article